VPAResearch pharmaceutical pipeline Research Series:
VPAResearch pipeline research is one of the reputed and trusted series worldwide.
Our coverage includes- 42000+ pipeline drugs in our internal databases
All databases updated daily by our in-house experts crawling through 10,000+ sources
In-depth analysis of end-to-end pipeline development included
Key pharmaceutical Pipeline Facts-
The global pharmaceutical sales are forecast to increase at 6.8% CAGR from 2019 to 2025 driven primarily by launch of new therapies.
Consistency in R&D investments remains a core strength of pharmaceutical industry
Novartis remains market leader worldwide but Pfizer and Roche are quickly gaining market shares
Bio-pharmaceutical pipeline is growing steadily with over 5,000 first in class products being developed
Oncology treatment remains the most widely invested research area, followed by central nervous system, infectious diseases and immunology drugs developed
Around 35% of new active substances launched in 2018 have orphan drug designation
VPAResearch Clinical Trials Research Series: